Is AGN.CN undervalued or overvalued?

As of 2025-03-16, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is -0.07 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 CAD, the upside of Algernon Pharmaceuticals Inc is -166.39%. This means that AGN.CN is overvalued by 166.39%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-0.07 - -0.07	-0.07	-166.39%
P/E	(0.00) - (0.00)	(0.00)	-100.7%
DDM - Stable	(0.22) - 7.35	3.57	3465.7%
DDM - Multi	(0.29) - 7.80	(0.61)	-711.7%